Clinical Trial: A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) Treatment

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07875673) titled 'A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) Treatment' on Oct. 09.

Brief Summary: This Phase 1b study will evaluate different combinations of LCFA-01, LC103, and the antibiotic metronidazole in women with bacterial vaginosis (BV). Participants will be randomly assigned to one of five treatment groups and followed for approximately 13 weeks to assess the safety of the treatments, how well they work to treat BV, and their effects on the vaginal microbiome.

Up to 280 participants will be enrolled in this study

Study Start Date: Feb. 03, 2027

Study Type: INTERVENTIONAL

Condition: Bacter...